ArticleOncotarget2017

Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification.

Yongxin Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.